Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial | Sleep Medicine | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia.  Sleep. 2000;23:243-30810737342Google Scholar
2.
Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia.  J Psychiatr Res. 1997;31:333-3469306291Google ScholarCrossref
3.
Ohayon MM. Epidemiology of insomnia.  Sleep Med Rev. 2002;6:97-11112531146Google ScholarCrossref
4.
Pallesen S, Nordhus IH, Nielsen GH.  et al.  Prevalence of insomnia in the adult Norwegian population.  Sleep. 2001;24:771-77911683480Google Scholar
5.
Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences.  Clin Cornerstone. 2003;5:5-1514626537Google ScholarCrossref
6.
Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia.  Sleep. 1999;22:(suppl 2)  S379-S38510394611Google Scholar
7.
Avidan AY. Insomnia in the geriatric patient.  Clin Cornerstone. 2003;5:51-6014626541Google ScholarCrossref
8.
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders.  JAMA. 1989;262:1479-14842769898Google ScholarCrossref
9.
Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care.  Am J Psychiatry. 1997;154:1417-14239326825Google Scholar
10.
Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995.  Sleep. 1999;22:(suppl 2)  S386-S39310394612Google Scholar
11.
Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates.  Arch Gen Psychiatry. 1985;42:225-2322858188Google ScholarCrossref
12.
Riedel BW, Lichstein KL. Strategies for evaluating adherence to sleep restriction treatment for insomnia.  Behav Res Ther. 2001;39:201-21211153973Google ScholarCrossref
13.
Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States.  Sleep. 1999;22:(suppl 2)  S354-S35810394607Google Scholar
14.
Morin CM, Wooten V. Psychological and pharmacological approaches to treating insomnia.  Clin Psychol Rev. 1996;16:521-542. doi:10.1016/0272-7358(96)00027-xGoogle ScholarCrossref
15.
Hohagen F, Kappler C, Schramm E.  et al.  Prevalence of insomnia in elderly general practice attenders and the current treatment modalities.  Acta Psychiatr Scand. 1994;90:102-1087976454Google ScholarCrossref
16.
Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF III, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia.  JAMA. 1997;278:2170-21779417012Google ScholarCrossref
17.
Holbrook A, Crowther R, Lotter A, Endeshaw Y. The role of benzodiazepines in the treatment of insomnia.  J Am Geriatr Soc. 2001;49:824-82611454123Google ScholarCrossref
18.
Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.  BMJ. 2005;331:116916284208Google ScholarCrossref
19.
National Institutes of Health.  National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.  Sleep. 2005;28:1049-105716268373Google Scholar
20.
 Concern Over Ambien and Driving. “CBS News.” CBS television. March 8, 2006
21.
Stuever H. Snooze alarm: the pill that drove us to sleep. Washington Post. May 6, 2006: C01
22.
Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.  Health Psychol. 2006;25:3-1416448292Google ScholarCrossref
23.
Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia.  Am J Psychiatry. 1994;151:1172-11808037252Google Scholar
24.
Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis.  J Consult Clin Psychol. 1995;63:79-897896994Google ScholarCrossref
25.
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia.  Arch Intern Med. 2004;164:1888-189615451764Google ScholarCrossref
26.
Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev . 2003;(1):CD003161. Review12535460
27.
Edinger JD, Means MK. Cognitive-behavioral therapy for primary insomnia.  Clin Psychol Rev. 2005;25:539-55815951083Google ScholarCrossref
28.
Montgomery P, Dennis J. A systematic review of non-pharmacological therapies for sleep problems in later life.  Sleep Med Rev. 2004;8:47-6215062210Google ScholarCrossref
29.
Pallesen S, Nordhus IH, Kvale G. Nonpharmacological interventions for insomnia in older adults: a meta-analysis of treatment efficacy.  Psychotherapy. 1998;35:472-482Google ScholarCrossref
30.
Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.  JAMA. 1999;281:991-99910086433Google ScholarCrossref
31.
Moldofsky H. Sleep and pain.  Sleep Med Rev. 2001;5:385-39612531004Google ScholarCrossref
32.
Edinger JD, Fins A. The distribution and clinical significance of sleep time misperceptions among insomniacs.  Sleep. 1995;18:232-2397618020Google Scholar
33.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician.  J Psychiatr Res. 1975;12:189-1981202204Google ScholarCrossref
34.
First MB, Spitzer RL, Gibbon M, Williams JBW. Structural Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department; 1995
35.
Rechtschaffen A, Kales A. A Manual of Standardised Terminology and Scoring System for Sleep Stages of Human Sleep. Los Angeles: University of California at Los Angeles, Brain Information Service/Brain Research Institute; 1968
36.
Lorenzo JL, Barbanoj MJ. Variability of sleep parameters across multiple laboratory sessions in healthy young subjects: the “very first night effect.”  Psychophysiology. 2002;39:409-41312212632Google ScholarCrossref
37.
Lichstein KL, Riedel BW. Behavioral assessment and treatment of insomnia: a review with an emphasis on clinical application.  Behav Ther. 1994;25:659-688Google ScholarCrossref
38.
Morin CM. Insomnia: Psychological Assessment and Management. New York, NY: Guilford Press; 1993
39.
Morgan K, Thompson J, Dixon S, Tomeny M, Mathers N. Predicting longer-term outcomes following psychological treatment for hypnotic-dependent chronic insomnia.  J Psychosom Res. 2003;54:21-2912505552Google ScholarCrossref
40.
Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed.  Sleep. 1987;10:45-563563247Google Scholar
41.
Bootzin RR, Nicassio PM. Behavioral treatments for insomnia. In: Hersen M, Eissler R, Miller P, eds Progress of Behavior Modification Vol 6.. New York, NY: Academic Press; 1978:1-45
42.
Beck AT. Cognitive Therapy and the Emotional Disorders. New York, NY: International University Press; 1976
43.
Jacobsen E. You Can Sleep Well. New York, NY: McGraw-Hill Book Co; 1938
44.
Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.  Drug Saf. 1999;21:457-46910612270Google ScholarCrossref
45.
Noble S, Langtry HD, Lamb HM. Zopiclone: an update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.  Drugs. 1998;55:277-3029506247Google ScholarCrossref
46.
Norwegian Institute of Public Health.  Drug Consumption in NorwayOslo: Norwegian Institute of Public Health; 2004
47.
Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Laurence Erlbaum; 1988
48.
Smith MT, Perlis ML, Park A.  et al.  Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.  Am J Psychiatry. 2002;159:5-1111772681Google ScholarCrossref
49.
Bastien CH, Morin CM, Ouellet MC, Blais FC, Bouchard S. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations.  J Consult Clin Psychol. 2004;72:653-65915301650Google ScholarCrossref
50.
Strom L, Pettersson R, Andersson G. Internet-based treatment for insomnia: a controlled evaluation.  J Consult Clin Psychol. 2004;72:113-12014756620Google ScholarCrossref
51.
Morin CM, Beaulieu-Bonneau S, LeBlanc M. Self-help treatment for insomnia: a randomized controlled trial.  Sleep. 2005;28:1319-132716295218Google Scholar
Original Contribution
June 28, 2006

Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial

Author Affiliations
 

Author Affiliations: Department of Clinical Psychology (Drs Sivertsen, Omvik, Havik, Kvale, Nielsen, and Nordhus); Department of Psychosocial Science (Dr Pallesen); Norwegian Competence Center for Sleep Disorders (Drs Bjorvatn, Pallesen, and Nordhus); and Department of Public Health and Primary Health Care (Dr Bjorvatn), University of Bergen, Bergen, Norway.

JAMA. 2006;295(24):2851-2858. doi:10.1001/jama.295.24.2851
Abstract

Context Insomnia is a common condition in older adults and is associated with a number of adverse medical, social, and psychological consequences. Previous research has suggested beneficial outcomes of both psychological and pharmacological treatments, but blinded placebo-controlled trials comparing the effects of these treatments are lacking.

Objective To examine short- and long-term clinical efficacy of cognitive behavioral therapy (CBT) and pharmacological treatment in older adults experiencing chronic primary insomnia.

Design, Setting, and Participants A randomized, double-blinded, placebo-controlled trial of 46 adults (mean age, 60.8 y; 22 women) with chronic primary insomnia conducted between January 2004 and December 2005 in a single Norwegian university-based outpatient clinic for adults and elderly patients.

Intervention CBT (sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relaxation; n = 18), sleep medication (7.5-mg zopiclone each night; n = 16), or placebo medication (n = 12). All treatment duration was 6 weeks, and the 2 active treatments were followed up at 6 months.

Main Outcome Measures Ambulant clinical polysomnographic data and sleep diaries were used to determine total wake time, total sleep time, sleep efficiency, and slow-wave sleep (only assessed using polysomnography) on all 3 assessment points.

Results CBT resulted in improved short- and long-term outcomes compared with zopiclone on 3 out of 4 outcome measures. For most outcomes, zopiclone did not differ from placebo. Participants receiving CBT improved their sleep efficiency from 81.4% at pretreatment to 90.1% at 6-month follow-up compared with a decrease from 82.3% to 81.9% in the zopiclone group. Participants in the CBT group spent much more time in slow-wave sleep (stages 3 and 4) compared with those in other groups, and spent less time awake during the night. Total sleep time was similar in all 3 groups; at 6 months, patients receiving CBT had better sleep efficiency using polysomnography than those taking zopiclone.

Conclusion These results suggest that interventions based on CBT are superior to zopiclone treatment both in short- and long-term management of insomnia in older adults.

Trial Registration clinicaltrials.gov Identifier: NCT00295386

×